Safety and antihypertensive effect of switching from eplerenone to esaxerenone in hypertensive patients.
Not Applicable
Recruiting
- Conditions
- hypertensive patients
- Registration Number
- JPRN-UMIN000037722
- Lead Sponsor
- Tokyo Women's Medical University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 200
Inclusion Criteria
Not provided
Exclusion Criteria
Patients with heart failure. Patients who have taken potassium-sparing diuretics (spironolactone, triamterene, and potassium canrenoate) or potassium preparations during the last 8 weeks. Patients whose serum potassium level exceeded 5.0 mEq/L. Patients with severe renal dysfunction (eGFR <30 mL/min/1.73m2).
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Changes in blood pressure, pulse rate, serum levels of potassium and creatinine, and eGFR.
- Secondary Outcome Measures
Name Time Method